"Benchmark Research is one of the top clinical research firms - trusted worldwide in conducting investigational studies for the development of new vaccines and medicines to help prevent a wide range of illnesses. Get Paid to Participate. Join other adults, seniors, teens and children. As of 2016, more than 25,000 people have participated in our studies."

During the past decade, Benchmark Research conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 30 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 16 clinical trials were completed. i.e. 53.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Benchmark Research" #1 sponsor was "Pfizer" with 16 trials, followed by "ModernaTX, Inc." with 11 trials sponsored, "Protein Sciences Corporation" with 5 trials sponsored, "MedImmune LLC" with 3 trials sponsored and "Baxter Healthcare Corporation" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Benchmark Research" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 5 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Benchmark Research" are "Influenza" (14 trials), "COVID-19" (4 trials), "Pneumococcal Disease" (4 trials), "SARS-CoV-2" (4 trials) and "SARS-CoV-2 Infection" (4 trials). Many other conditions were trialed in "Benchmark Research" in a lesser frequency.

Most popular intervention types in "Benchmark Research" are "Biological" (47 trials), "Drug" (22 trials), "Other" (12 trials), "Diagnostic Test" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Saline" (4 trials), "mRNA-1010" (3 trials), "mRNA-1273" (3 trials) and "mRNA-1345" (3 trials). Other intervention names were less common.

The vast majority of trials in "Benchmark Research" are 74 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Benchmark Research". undefined are not yet recruiting, 3 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Benchmark Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Benchmark Research, 8 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".